Schizophrenia Clinical Trial
Official title:
The Effects of High-Definition High-Frequency Transcranial Random Noise Stimulation Over Bilateral Prefrontal Cortex on Illness Symptoms, Clinical Outcomes, Autonomic Function and Brain Oscillatory Activity in Schizophrenia Patients
The study aimed to investigate the effects of high-definition transcranial random noise stimulation over bilateral prefrontal cortex on psychopathological symptoms, other clinical outcomes, autonomic functioning ,and brain oscillatory activity in schizophrenia patients.
Negative symptoms of schizophrenia include blunted affect, avolition-apathy, alogia and
anhedonia-asociality and are closely linked to neurocognitive deficits. Negative symptoms and
neurocognitive impairments are associated with poor functional outcomes. Prefrontal cortical
dysfunction, particularly hypoactivity of the dorsolateral prefrontal cortex (DLPFC) has
consistently been reported in schizophrenia and suggested to underlie the pathophysiology of
negative symptom and neurocognitive impairment. Atypical antipsychotics, the mainstream
treatment for schizophrenia, are known to show little effect on patients' hypofrontality and
some of them (e.g., strong dopamine receptor antagonists and clozapine) are even associated
with a decrease in prefrontal activation. Furthermore, good evidence that atypical
antipsychotics have any beneficial effect on negative symptoms or neurocognitive impairments
is still lacking. Currently, negative symptoms and cognitive deficits remain the most
important unmet therapeutic needs in schizophrenia, which have driven the development of
novel and effective treatments targeting the core pathophysiological features of the
deficits, e.g., non-invasive brain stimulation (NIBS) of DLPFC.
Transcranial random noise stimulation (tRNS) is a neuromodulation technique that applies a
weak alternating current over the brain cortex at random frequencies (0.1- 640 Hz), i.e., the
current oscillating randomly in amplitude over time and within defined thresholds, following
the Gaussian curve around a midpoint, called "offset". Switching the offset from zero towards
positive current strength, e.g.1 mA inhibits negative polarisation during the oscillations
and provides a unidirectional current flow. It is well-known that when the neurons are
stimulated under a constant electrical field, the neuronal membranes adapt themselves and
return to their original resting state (i.e., homeostasis of system or the homeostatic
phenomena of ion neuron channels). Given the nature of constantly changing electrical field
of tRNS, a potential advantage of this type of NIBS is that it might not result in
homeostasis of the neural system, the mechanism thought to account for the limit to
additional increases in cortical excitability with prolonged constant electrical stimulation.
The pilot study in humans reported that tRNS does not work in a polarity dependent way and
can increase cortical excitability under both electrodes placed on the scalp. Specifically,
tRNS over the motor area positively modulates cortical excitability and improves motor
learning, possibly through the mechanism of long-term potentiation (LTP). Given the
particular wave shape of tRNS, it might induce temporal summation of small depolarizing
currents, which could interact with the activity of the engaged neurons and therefore improve
performance in perceptual learning. Therefore, tRNS of neurons provides the driving force for
a synaptic potentiation-like phenomenon. The effect was more pronounced with high frequency
(hf)-tRNS, which was possibly related to the range of frequency applied (100-640 Hz). Since
the time constant of the neuronal cell body and dendrites has been known between 1-10 ms,
stimulation at the frequency range between 100-1000 Hz may be appropriate for exerting a
meaningful effect on neuronal communication. In addition, a prolonged opening of the
voltage-gated sodium channels is also a possible underlying neuronal correlate for hf-tRNS to
elicit more cortical excitability shifts and more pronounced plasticity changes. Another
proposed mechanism through which tRNS exerts behavioral effects is the stochastic resonance
phenomenon. tRNS represents a stimulation that gives rise to nonfinalized random activity in
the system i.e., noise. In a linear system, noise generally reduces behavioral performance,
but non-linear systems (e.g., the brain) may apply noise to improve performance via
stochastic resonance. That is, neurons become sensitive to a specific range of weak inputs in
the presence of an optimal level of neuronal noise, and the behavioral performance is
therefore facilitated. To the investigator's knowledge, the treatment of schizophrenia with
tRNS has only been reported in case studies as an add-on treatment for negative symptoms in a
medicated patient or as a monotherapy in alleviating delusions and enhancing insight of the
illness in a drug-free patient.
The study aimed to investigate the effects of add-on high-definition high-frequency
transcranial random noise stimulation over bilateral prefrontal cortex on negative symptoms
and other psychopathological symptoms, clinical outcomes (insight levels, psychosocial
functioning, quality of life, beliefs about medication adherence, severity of extrapyramidal
symptoms, neurocognitive function), autonomic functioning ,and brain oscillatory activity in
schizophrenia patients.
Study design: randomized double-blind, sham-controlled study design.
Participants: 36 patients having a diagnosis of schizophrenia or schizoaffective were
randomly allocated to receive 20 minutes of active 2-mA HD-hf-tRNS or sham stimulation twice
a day on 5 consecutive weekdays. These participants were assessed at baseline, after
intervention, one-week and one-month follow-ups.
Active or sham stimulation: tRNS was delivered by a battery-operated device (Eldith DC
stimulator Plus, neuroConn, Ilmenau, Germany) via 5 carbon rubber electrodes (1 cm radius,
high-definition 4 × 1 rings configuration with a gel layer of 2.0 mm), with 2 mA amplitude,
offset at 1 mA, frequency 100-640 Hz, for 20 min with 15 s ramp-in/ramp-out. The combined
impedance of all electrodes was kept below 15 kΩ, as measured by NeuroConn DC stimulator Plus
device, using electrolyte gel. The anode was placed over International 10-10 electrode
position AF3 (a point midway between F3 and Fp1), with cathodes (reference electrodes) at
AF4, F2, F6 and FC4. The sessions were conducted twice a day on 5 consecutive working days.
In the sham group, current was applied for 30 s after upward ramping and then terminated.
Immediately after the first stimulation session, all participants were asked to answer the
question of whether they received active or sham treatment.
Others: see Arms and Interventions, Eligibility Criteria or Outcome Measures.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |